Articles

IBJ Life Sciences Power Breakfast transcript – 2016

IBJ gathered leaders in the life sciences industry for a Power Breakfast panel discussion April 21. Panel members included Colleen Hittle, managing director of Navigant; Suresh Garimella, Purdue University’s executive vice president of research and partnerships; Brian Barker, general manager of U.S. Seeds for Dow AgroSciences; Kristin Sherman, former chief financial officer of Calibrium LLC; and David Johnson, CEO of BioCrossroads.

Read More

Dow Agro’s revenues slide ahead of DuPont merger

Indianapolis-based agricultural Dow Agro on Thursday said revenue in the first quarter was $1.6 billion, down 16 percent from a year ago, as the company was hurt by high inventories, currency headwinds and lower prices.

Read More

IU Health boosts minimum wage to $11 an hour

Many employees already made more than the state and national minimum of $7.25 per hour, but the hospital system said it wanted to be proactive. Workers who already made $11 to $12.99 an hour were also given a raise.

Read More

Indy life sciences firm sells for $127 million

Privately-held Biostorage Technologies Inc., which specializes in biological sample storage, has been purchased by a Massachusetts-based firm in one of central Indiana’s largest disclosed-price acquisitions of the past year.

Read More

Teen births fall in Indiana, nation

Teen births have fallen to a record low in the United States and dropped sharply in Indiana too, a development that could save taxpayers millions of dollars in public health services and other assistance.

Read More

Thank you and farewell

Just as a reminder, this is the end of my run as the voice of The Dose. I’m handing over the blog, starting Friday, to John Russell, IBJ’s new health care reporter.

Read More

Once debt-laden, IU Health’s finances in tip-top shape

When CEO Dan Evans relinquishes the reins of Indiana University Health in April, he will hand his successor Dennis Murphy a hospital system with a pristine balance sheet. That’s a big change for IU Health, which when the Great Recession hit was debt-laden and cash-strapped.

Read More
rop-dna-research-010416-2col.jpg

Deal puts IU doctor’s research on path to market

A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.

Read More